Journals / Annals of Medical Research / 2022 / Cilt: 29 - Sayı: 3

Comparison of percutaneous coronary intervention of saphenous venous graft versus native artery in acute myocardial infarction

Pages
211–214
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Aim: Percutaneus coronary intervention (PCI) is recommended as the first choice in saphenous vein graft (SVG) occlusions because of the high mortality linked with repeated coronary artery by-pass grafting (CABG).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Percutaneus coronary intervention (PCI) is recommended as the first choice in saphenous vein graft (SVG) occlusions because of the high mortality linked with repeated coronary artery by-pass grafting (CABG).
📊
Key Findings & Data:In total, 95 patients with a CABG history who were admitted to our hospital with an AMI and received PCI were included in the study.
💡
Conclusion & Impact:Diabetes mellitus (DM) should be kept in mind as a predictive factor.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Percutaneus coronary intervention (PCI) is recommended as the first choice in saphenous vein graft (SVG) occlusions because of the high mortality linked with repeated coronary artery by-pass grafting (CABG). We observed percutaneous interventions performed in patients presenting with acute myocardial infarction (AMI) with a CABG history in terms of both short- and long-term efficacy and safety. Materials and Methods: The study was conducted retrospectively at a single center. In total, 95 patients with a CABG history who were admitted to our hospital with an AMI and received PCI were included in the study. Results: In-hospital deaths occurred in 4 (4.2%) patients, 30-day major adverse cardiac event (MACE) were present in 8 (8.4%) patients, and 6 (6.3%) patients experienced firstyear target vessel revascularization (TVR). A significant difference was not observed in in-hospital death, 30-days MACE, 1-year TVR and 1-year MACE rates among the patient groups who had PCI in the graft vessel or native vessel. Conclusion: Our study revealed that a significant difference was not present in terms of MACE in the intervention of SVGs or native coronary arteries. Diabetes mellitus (DM) should be kept in mind as a predictive factor.

🔖

Cite This Article

İBİSOĞLU, E., BOYRAZ, B. (2022). Comparison of percutaneous coronary intervention of saphenous venous graft versus native artery in acute myocardial infarction. Annals of Medical Research, Cilt: 29 - Sayı: 3, 211–214. https://ajindex.com/articles/445646

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Farag M, Gue YX, Brilakis ES, Egred M. Meta-analysis Comparing Outcomes of Percutaneous Coronary Intervention of Native Artery Versus Bypass Graft in Patients With Prior Coronary Artery Bypass Grafting. Am J Cardiol. 2021 Feb 1
  2. doi: 10.1016/j.amjcard.2020.10.062. Epub 2020 Nov 2.PMID: 33144169 2. J Tatoulis, BF Buxton, JA Fuller. Patencies of 2127 arterial to coronary conduits over 15 years. Ann Thorac Surg 2004
  3. 101 3. ES Brilakis, M Lee, J Mehilli, K Marmagkiolis, J Rodes-Cabau, R Sachdeva, A Kotsia, G Christopoulos, BV Rangan, A Mohammed, S Banerjee. Saphenous vein graft interventions. Curr Treat Options Cardiovasc Med 2014
  4. 301 4. S Bhogal, HB Panchal, J Bagai, S Banerjee, ES Brilakis, D Mukherjee, G Kumar, M Shanmugasundaram, TK Paul. Drug- Eluting Versus Bare Metal Stents in Saphenous Vein Graft Intervention: An Updated Comprehensive Meta-Analysis of Randomized Trials. Cardiovasc Revasc Med 2019
  5. 767 5. Hong MK, Mintz GS, Lee CW, Kim YH, Lee SW, Song JM, et al. Incidence, Mechanism, Predictors, and Long-Term Prognosis of Late Stent Malapposition after Bare-Metal Stent Implantation. Circulation. 2004 Feb 24
  6. 109(7):881–6. 6. Hong MK, Mintz GS, Lee CW, Park DW, Park KM, Lee BK, et al. Late stent malapposition after drug-eluting stent implantation: An intravascular ultrasound analysis with long-term followup. Circulation. 2006 Jan
  7. 113(3):414–9. 7. Califf RM, Abdelmeguid AE, Kuntz RE, Popma JJ, Davidson CJ, Cohen EA, Kleiman NS, Mahaffey KW, Topol EJ, Pepine CJ, Lipicky RJ, Granger CB, Harrington RA, Tardiff BE, Crenshaw BS, Bauman RP, Zuckerman BD, Chaitman BR, Bittl JA, Ohman EM. Myonecrosis after revascularization procedures. J Am Coll Cardiol. 1998 Feb
  8. 31(2):241-51. doi: 10.1016/s0735- 1097(97)00506-8. 8. Miró Ò, Martínez-Nadal G, Koechlin L, Coll-Vinent B, Gil V, Aguiló S, Galicia M, García-Martínez A, Ortega M, Strebel I, Ayala PL, Gualandro DM, Boeddinghaus J, Nestelberger T, Bragulat E, Sánchez M, Müller C, López-Barbeito B. Influence of previous coronary artery bypass grafting in the difficulty of acute coronary syndrome diagnosis. Eur J Emerg Med. 2021 Apr 1
  9. 28(2):125-135. doi: 10.1097/MEJ.0000000000000755. 9. Deharo P, Strange JW, Mozid A. Primary percutaneous coronary intervention of native chronic total occlusions to treat ST elevation myocardial infarction secondary to acute vein graft occlusion. Catheter Cardiovasc Interv. 2017 Aug 1
  10. 90(2):251-256. doi: 10.1002/ccd.26905. Epub 2017 Feb 10. 10. Xenogiannis I, Niko